N/A
Completed N=230
Study Comparing Marathon Polyethylene and Enduron Polyethylene Acetabular Liners Used in Total Hip Arthroplasty
Osteoarthritis · Arthritis · Joint Diseases · Musculoskeletal Diseases
Source: ClinicalTrials.gov NCT01121146 ↗
Enrolled (actual)
230
Serious AEs
5.7%
Results posted
Nov 2014
Primary outcomePrimary: Incidence of Clinically Significant Osteolysis — 0; 15 unrevised THAs
Summary
The purpose of the study is to determine whether crosslinked Marathon and standard Enduron polyethylene liners show differences in bone loss around the hip implant.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence of Clinically Significant Osteolysis |
0; 15 | — |
| SECONDARY Polyethylene Wear |
.04; 0.22 | — |
| SECONDARY Rate of Reoperation |
2; 11 | — |
| SECONDARY Harris Hip Score |
88; 86 | — |
| SECONDARY Patient Satisfaction |
99; 97 | — |
Eligibility Criteria
Inclusion Criteria
(from original study)
-Elective total hip replacement patient
(from 10-year follow-up)
- Consented to the original study.
- Received a Duraloc 100 cup with either a crosslinked Marathon or standard Enduron liner.
- Received an AML/Solution or a Prodigy stem with 28mm cobalt chrome femoral head.
Exclusion Criteria
(from original study)
-None
(from 10-year follow-up)
- Patient did not receive device as specified in inclusion criteria.
- Patient refused to consent to the 10-year follow-up.
Data sourced from ClinicalTrials.gov (NCT01121146). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.